Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Abida Shaheen, Muzammil Hasan Najmi, Waseem Saeed & Zia-Ur-Rehman Farooqi. (2012) Pharmacokinetics of standard dose regimens of rifampicin in patients with pulmonary tuberculosis in Pakistan. Scandinavian Journal of Infectious Diseases 44:6, pages 459-464.
Read now
Read now
T.T. Mariappan, Saranjit Singh, Rajesh Pandey & G.K. Khuller. (2005) Determination of Absolute Bioavailability of Rifampicin by Varying the Mode of Intravenous Administration and the Time of Sampling. Clinical Research and Regulatory Affairs 22:3-4, pages 119-128.
Read now
Read now
Articles from other publishers (9)
Prakash Khadka, Shubhra Sinha, Ian G. Tucker, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2021) Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats. European Journal of Pharmaceutics and Biopharmaceutics 162, pages 1-11.
Crossref
Crossref
Harinder Singh, Sahil Jindal, Mandeep Singh, Gaurav Sharma & Indu Pal Kaur. (2015) Nano-formulation of rifampicin with enhanced bioavailability: Development, characterization and in-vivo safety. International Journal of Pharmaceutics 485:1-2, pages 138-151.
Crossref
Crossref
Sean Kim, Joseph E. Dinchuk, Monique N. Anthony, Tami Orcutt, Mary E. Zoeckler, Mary B. Sauer, Kathleen W. Mosure, Ragini Vuppugalla, James E. GraceJr.Jr., Jean Simmermacher, Heidi A. Dulac, Jennifer Pizzano & Michael Sinz. (2010) Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Induction. Drug Metabolism and Disposition 38:1, pages 16-24.
Crossref
Crossref
C. Becker, J.B. Dressman, H.E. Junginger, S. Kopp, K.K. Midha, V.P. Shah, S. Stavchansky & D.M. Barends. (2009) Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin. Journal of Pharmaceutical Sciences 98:7, pages 2252-2267.
Crossref
Crossref
Dimitri Semizarov & Eric Blomme. 2008. Genomics in Drug Discovery and Development. Genomics in Drug Discovery and Development
219
291
.
Justin J. Wilkins, Radojka M. Savic, Mats O. Karlsson, Grant Langdon, Helen McIlleron, Goonaseelan Pillai, Peter J. Smith & Ulrika S. H. Simonsson. (2008) Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption. Antimicrobial Agents and Chemotherapy 52:6, pages 2138-2148.
Crossref
Crossref
Shrutidevi Agrawal & Ramesh Panchagnula. (2005) Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms. Biopharmaceutics & Drug Disposition 26:8, pages 321-334.
Crossref
Crossref
Orish E. Orisakwe, Patrick U. Agbasi, Sabinus I. Ofoefule, Ndidi A. Ilondu, Onyenmechi J. Afonne, Chikere A. Anusiem, Cajetan E. Ilo & Steve O. Maduka. (2004) Effect of Pefloxacin on the Urinary Excretion of Rifampicin. American Journal of Therapeutics 11:1, pages 13-16.
Crossref
Crossref
Xiao G. Liu, Prem K. Narang & Ronald C. Li. (2001) Induction of hepatic and presystemic metabolism of antipyrine in the mice: Rifampicin versus rifabutin. European Journal of Drug Metabolism and Pharmacokinetics 26:4, pages 209-213.
Crossref
Crossref